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Simple Summary: Host antiviral defense/viral counter-defense is an interesting topic in modern
virology. RNA silencing is the primary antiviral mechanism in insects, plants, and fungi, while
viruses encode and utilize RNA silencing suppressors against the host defense. Hypoviruses are
positive-sense single-stranded RNA viruses with phylogenetic affinity to the picorna-like supergroup,
including animal poliovirus and plant potyvirus. The prototype hypovirus Cryphonectria hypovirus
1, CHV1, is one of the best-studied fungal viruses. It is known to induce hypovirulence in the chestnut
blight fungus, Cryphonectria parasitica, and encode an RNA silencing suppressor. CHV4 is another
hypovirus asymptomatically that infects the same host fungus. This study shows that the N-terminal
portion of the CHV4 polyprotein, termed p24, is a protease that autocatalytically cleaves itself from
the rest of the viral polyprotein, and functions as an antiviral RNA silencing suppressor.
Abstract: Previously, we have reported the ability of a symptomless hypovirus Cryphonectria
hypovirus 4 (CHV4) of the chestnut blight fungus to facilitate stable infection by a co-infecting
mycoreovirus 2 (MyRV2)—likely through the inhibitory effect of CHV4 on RNA silencing (Aulia
et al., Virology, 2019). In this study, the N-terminal portion of the CHV4 polyprotein, termed p24, is
identified as an autocatalytic protease capable of suppressing host antiviral RNA silencing. Using a
bacterial expression system, CHV4 p24 is shown to cleave autocatalytically at the di-glycine peptide
(Gly214-Gly215) of the polyprotein through its protease activity. Transgenic expression of CHV4
p24 in Cryphonectria parasitica suppresses the induction of one of the key genes of the antiviral
RNA silencing, dicer-like 2, and stabilizes the infection of RNA silencing-susceptible virus MyRV2.
This study shows functional similarity between CHV4 p24 and its homolog p29, encoded by the
symptomatic prototype hypovirus CHV1.
Keywords: mycovirus; reovirus; hypovirus; Cryphonectria parasitica; co-infection; RNA silencing;
RNAi suppressor; chestnut blight fungus; Dicer
1. Introduction
Although RNA silencing is increasingly believed to be the primary host defense
against viruses in fungi, it has only been shown in a few fungi (as exemplified in the model
filamentous ascomycetous fungi, Cryphonectria parasitica [1,2], Fusarium graminearum [3,4],
Magnaporthe oryzae [5], Colletotrichum higginsianum [6], Neurospora crassa [7], and Sclerotinia
sclerotiorum [8–10]). There are interesting similarities and dissimilarities in antiviral RNA
silencing among these fungi. The key enzyme genes associated with fungal, antiviral RNA
silencing are generally transcriptionally upregulated by virus infection [2,4,11], while their
induction magnitude is different between host fungi [7,12]. Specific fungal genes that are
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required for antiviral RNA silencing vary depending on fungal species. In C. parasitica
(chestnut blight fungus), only one dicer-like (dcl2) and one argonaute-like (agl2) gene play
central roles [1,2,13], and no RNA-dependent RNA polymerase (rdr) genes are required for
antiviral RNA silencing [14], unlike in plants [15–17]. In other fungi, additional dicer and
agl genes also contribute to antiviral RNA silencing [3,7,8].
Plant viruses encode RNA silencing suppressors, as exemplified by potyvirus HC-Pro,
tombusvirus P19, and luteovirus P0, which bind RNA silencing key players to impair their
functional roles or to lead their proteolytic degradation [18–20]. As in the case for plant
viruses, some fungal viruses have been shown to encode RNA silencing suppressors. The
best-studied example is a multifunctional protein, p29, encoded by the hypovirus CHV1
(Cryphonectria hypovirus 1, the prototype virus of the family Hypoviridae) that confers
hypovirulence to the host fungus. The functional roles attributed to this protein include
roles as a papain-like cysteine protease [21,22], symptom determinant [23,24], part of the
internal ribosome entry site (IRES) [25], as well as an RNA silencing suppressor [26]. CHV1
p29 suppresses RNA silencing by reducing the transcriptional induction level of dcl2 and
agl2 upon virus infection. A few other RNA silencing suppressors have previously been
identified from fungal viruses, including the S10 gene of a multi-segmented dsRNA virus,
Rosellinia necatrix mycoreovirus 3 (MyRV3, the family Reoviridae) [27], and the ORF2 gene
of a capsidless ssRNA virus, Fusarium graminearum virus 1 (FgV1, the proposed family
“Fusariviridae”) [4]. Similar to CHV1 p29, the FgV1 ORF2 suppressor with DNA binding
ability appears to suppress transcriptional upregulation of the key enzyme genes, i.e.,
FgDICER2 (a dcl) and FgAGO1 (an agl), of F. graminearum. Although the MyRV3 S10-coded
suppressor activity has been demonstrated in planta using an agroinfiltration assay, no
information about how the S10 (VP10) suppressor functions in fungal cells is available.
In a previous study, we described an interesting virus/virus interplay in C. parasitica,
in which a symptomless hypovirus, CHV4-C18 (Cryphonectria hypovirus 4, strain C-18),
a member of the family Hypoviridae, facilitates the stable infection of a mycoreovirus,
MyRV2 (mycoreovirus 2), which is susceptible to antiviral RNA silencing, and enhances its
replication and its vertical transmission through asexual spores [28]. This synergistic effect
of CHV4 onto MyRV2 appears to be imposed via suppression of antiviral RNA silencing
by CHV4. In this current study, we show that the N-terminal portion of the CHV4-C18
polyprotein, termed p24, is a protease that autocatalytically cleaves itself from the rest of
the viral polyprotein, and functions as an antiviral RNA silencing suppressor.
2. Materials and Methods
2.1. Viral and Fungal Strain
Viral and fungal strains used in this study are listed in Table 1. A field-collected
strain (C18) C. parasitica doubly infected by CHV4-C18 and MyRV2 and derivative isogenic
isolates that were either virus-free or singly infected with CHV4-C18 or MyRV2 were
described [28–30] earlier. The standard strain EP155 of C. parasitica [31], and its RNA
silencing-deficient mutant, dcl2 [1] were a generous gift from Donald L. Nuss, Institute
for Bioscience and Biotechnology, University of Maryland. A wild type CHV1 isolate
(CHV1-EP713) and its mutant, lacking the viral silencing suppressor, p29 (CHV1-∆p69),
were described previously [32,33]. Fungal strains were cultured as described earlier on
potato dextrose agar (PDA) plates on the bench top at 22–26 ◦C for maintenance and colony
phenotypic observations, and on PDA plates layered with cellophane for RNA preparation.
2.2. Fungal Transformation
Spheroplasts were prepared from C. parasitica strain C18 as described previously [34],
and transformed with an enhanced green fluorescent protein (eGFP) reporter (pCPXHY-
C18-dcl2pro::egfp) or CHV4 p24 expressing (pCPX-CHV4-p24) constructs. The eGFP reporter
strain containing an egfp gene under the control of the dcl2 promoter (~2 kb) of strain C18,
termed C18 dcl2pro::egfp, was constructed as described earlier [35]. pCPX-CHV4-p24 was
prepared by inserting the CHV4 p24 coding domain (amino acids 1–214) region flanked
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with a termination codon into the pCPXHY3 expression vector. Transformants were also
prepared with the empty pCPXHY3 vector and used as a control.
Table 1. Fungal and viral strains used in this study.
Strain Description Reference or Source
Fungal
C18 Cryphonectria parasitica field strain doublyinfected by MyRV2 and CHV4-C18 [29]
C18-VF Virus-free single conidial isolate of C18
C18p24 C18 transformed with the CHV4 p24coding domain This study
C18/MyRV2 C18 singly infected by MyRV2 [28]
C18/CHV4 C18 singly infected by CHV4-C18 [28]
C18/MyRV2+CHV4 C18 doubly infected by MyRV2 andCHV4 [28]
C18/∆p69 C18 singly infected by ∆p69 This study
C18p24/MyRV2 C18p24 infected by MyRV2 This study
EP155 Standard strain of Cryphonectria parasitica(virus-free) ATCC 38755
C18 ∆dcl2 dcl2 knock-out mutant of C18 (RNAsilencing defective, virus-free) [28]
Viral
MyRV2
Strain belonging to the species
Mycoreovirus 2 within the genus
Mycoreovirus
[29]
CHV4-C18 Strain of the species Cryphonectriahypovirus 4 [28]
CHV1-EP713 Prototype of the family Hypoviridae [32]
CHV1-∆p69 ORF-A deletion mutant of CHV1-EP713lacking the p29 and p40 coding domain [33]
2.3. Functional Expression in Escherichia coli of the Putative p24 Proteinase Domain of CHV4
The N-terminal region of the CHV4 polyprotein (map positions 287 to 1706; encoding
amino acids 1 to 473, which include a coding region of the tentative protease p24, amino
acid position 1 to 214, with the estimated molecular weight of 52 kDa) was amplified by
RT-PCR and cloned into the expression vector pCold I (Takara Bio, Kusatsu, Japan) that
had been modified to include GST (glutathione S transferase) in the expression cassette.
The CHV4-derived 52kDa coding region was fused in frame with a His (hexa histidine)-tag
with GST at the N-terminus and an HA (hemagglutinin)-tag at the C-terminus (pCold-
His/GST-CHV4 52kDa-HA). Escherichia coli strain BL21 (DE3) (Promega, Madison, WI,
USA) was transformed with this construct. Induction of the recombinant protein with IPTG
(isopropyl-β-d-thiogalactopyranoside) at 15 ◦C for 4 h was according to the manufacturer’s
instructions (Takara Inc., Kusatsu, Japan). The affinity-purified recombinant protein was
examined by SDS-polyacrylamide gel electrophoresis (PAGE).
Proteins in purified preparations separated on an SDS-PAGE gel were transferred onto
polyvinylidene difluoride (PVDF) membrane using 10 mM CAPS buffer containing 10%
methanol and followed with amido black staining (0.1% amido black, 10% acetic acid, 40%
methanol). The specific band obtained from amido black staining was then excised from
the membrane and processed for amino acid sequences on a gas-phase protein sequencer
Shimadzu Model PPSQ-31A (Kyoto, Japan) at the Department of Instrumental Analysis and
Cryogenics, Advanced Science Research Center, Okayama University (Okayama, Japan).
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2.4. RNA Extraction, RT-PCR and RNA Blotting
Total RNA extraction and Northern blotting were performed as described previ-
ously [34]. Digoxigenin (DIG)-labeled DNA probes prepared by PCR (PCR DIG Labeling
Mix, Roche) were used to detect targeted RNAs, i.e., dcl2 mRNA, MyRV2-S10 segment, and
CHV4-C18. The accumulation levels of targeted RNAs were quantified by ImageJ software
(Version 1.52v, National Institutes of Health, Bethesda, MD, USA) and normalized to those
of ribosomal RNA (28S rRNA). To confirm the virus infection, conventional RT-PCR and
one-step colony RT-PCR were carried out as described earlier using QuickTaq (Toyobo,
Osaka, Japan) or PrimeScript® OneStep RT-PCR Ver.2 (Takara Bio), respectively [28,36].
Table S1 lists all primers used in this study. RT-qPCR was performed as described by Hyodo
et al. [37] to quantify dcl2 mRNA and MyRV2 S4 mRNA. Primer pairs, double-stranded
RNAs were isolated by the method of Eusebio-Cope and Suzuki [34].
2.5. Small RNA Analysis
Total RNA extracted from virus-infected C. parasitica C18 strain was subjected to small
RNA sequencing analysis. Small RNA cDNA library preparation and subsequent deep
sequencing with Illumina platform (San Diego, CA, USA) (HiSeq 2500; 50-bp single-ends
reads) were conducted by Macrogen Inc. (Tokyo, Japan). Raw reads (total read numbers:
CHV1-EP713/C18 = 33,766,667; CHV4-C18/C18 = 36,794,504; MyRV2/C18 46 = 892,744;
CHV4-C18 + MyRV2/C18 = 40,103,587) were trimmed by removing the adapter with
low-quality base and size filtering (15 to 32 nt in length), the retained reads in each library
were mapped into each virus genome (CHV1-EP713 and CHV4-C18) or respective genomic
segments (MyRV2) using CLC Genomic Workbench (version 11; CLC Bio-Qiagen, Aarhus,
Denmark). The mapped virus-derived small RNA reads were used for in-depth analysis
with the program MISIS-2 [38].
2.6. Confocal Laser Scanning Microscopy of the Reporter Fungal Strain Infected by
Diverse Viruses
A micro cover glass (22 mm × 22 mm, thickness 0.12–0.17 mm) (Matsunami, Osaka,
Japan) was placed on the top of cellophane-overlaid PDA. A small plug of the fungal
culture of the GFP reporter strain infecting each of the tested viruses (MyRV2, CHV4-C18,
CHV1-EP713, or CHV1-∆p69) was placed at the edge of micro cover glass, and allowed to
grow for three days. After the mycelia grew between the micro cover glass and cellophane,
the clover glass with mycelia was detached and placed on top of a micro slide glass
(Matsunami). GFP expression was observed using Olympus Fluoview FV1000 confocal
laser scanning microscope (Olympus, Tokyo, Japan).
3. Results
3.1. Cryphonectria Parasitica Hypovirus 4 Suppresses Upregulation of dcl2
It was previously shown that CHV4 suppresses the transcriptional upregulation of
dcl2 induced by co-infecting MyRV2 in C. parasitica strain C18 [28]. Recently, an eGFP-
based reporter system for monitoring dcl2 transcript levels was developed in the genetic
background of standard C. parasitica strain EP155, in which the dcl2 promoter was linked to
an egfp gene (pCPXHY-dcl2pro::egfp) [39]. The 2-kbp dcl2 promoter region of strain C18 was
used to replace the corresponding region of pCPXHY-dcl2pro::egfp (namely pCPXHY-C18-
dcl2pro::egfp). Fungal transformants expressing this construct in the virus-free C18 genetic
background were prepared and fused with C18 isolates singly infected by CHV4-C18,
MyRV2 and CHV1-p69, respectively, or doubly infected by CHV4-C18 and either MyRV2
or CHV1-p69 (Table 1). First, the RNA-silencing suppressor activities of CHV4-C18 in dcl2
transcriptional upregulation were confirmed using the reporter system. Upon infection
of the reporter fungal strain by the strong RNA silencing inducer viruses, CHV1-p69 or
MyRV2, the fungal strain fluoresced brightly (Figure 1A, top row). However, this green
fluorescence was significantly reduced by co-infection by CHV4 (Figure 1B). Similar to
CHV1 infection, no green fluorescence was detectable in the reporter fungal strain infected
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by CHV4. A similar eGFP fluorescence pattern was observed in an independent set of
fungal strains (Figure S1). The reduction in levels of dcl2 and egfp transcripts by CHV4
infection was also confirmed by northern blotting (Figure 1C), in which the transcript levels
were reduced by four to seventeen-fold.




Figure 1. CHV4 suppresses antiviral RNA silencing via inhibiting dcl2 transcriptional upregula-
tion. (A) The organization of a reporter constructs pCPXHY-C18-dcl2pro::egfp. An egfp gene fused 
with a 2.2 kbp C. parasitica C18 genomic sequence containing the dcl2 promoter region was cloned 
into pCPXHY1 and used to transform a virus-free isogenic isolate of C. parasitica C18 strain (C18-
VF) [28]. (B and C) CHV4-mediated suppression of the GFP reporter induction. The reporter fun-
gal strain with pCPXHY-C18-dcl2pro::egfp (C18/dcl2pro-eGFP) was infected by CHV1-∆p69 and 
MyRV2 (B), which are strong dcl2 triggers, or CHV4 and CHV1 wild type (C). Values in the re-
spective panels of (B) show the relative intensity of the reporter eGFP green fluorescence quanti-
fied by ImageJ, with the CHV1-∆p69-infected strain expressed as 100. Total RNA fractions were 
obtained from two biological replicates of the reporter fungal strain (C18/dcl2pro-eGFP) infected 
by each virus, and subjected to northern blotting to monitor dcl2 and egfp transcript levels. Hybrid-
ization and probe preparation are described in the Materials and Method section. Mean values of 
band intensity in the northern blots (C) quantified by ImageJ are shown below each blot. RT-PCR 
detection for CHV4 infection or dsRNA electrophoretic gel analysis for MyRV2 (viral dsRNA ge-
nome) or CHV1 and CHV1-∆p69 (viral replicative dsRNA form) infection in the reporter fungal 
strain were conducted. Ribosomal RNA (28S rRNA) was used as a loading control. 
These results confirm that CHV4 is able to impair the otherwise strong transcrip-
tional induction of dcl2 triggered by infection with heterologous viruses (MyRV2 or 
CHV1-p69) that otherwise induce antiviral RNA silencing. 
3.2. Co-infection Results in Alterations in Profiles of Virus-Derived Small RNAs. 
Figure 1. CHV4 suppresses antiviral RNA silencing via inhibiting dcl2 transcriptional upregulation.
(A) The organization of a reporter constructs pCPXHY-C18-dcl2pro::egfp. An egfp gene fused with
a 2.2 kbp C. parasitica C18 genomic sequence containing the dcl2 promoter region was cloned into
pCPXHY1 an used to transform a virus-free isog nic isolate of C. parasitica C18 strain (C18-VF) [28].
(B,C) CHV4-mediated suppression of the GFP reporter induction. The reporter fungal strain with
pCPXHY-C18-dcl2pro::egfp (C18/dcl2pro-eGFP) was infected by CHV1-∆p69 and MyRV2 (B), which
are strong dcl2 triggers, or CHV4 and CHV1 wild type (C). Values in the respective panels of (B) show
the relative in ensity f the orter eGFP green fluorescence quantified by ImageJ, with the CHV1-
∆p69-infected strain expressed as 100. Total RNA fractions were obtained from two biological
replicates of the reporter fungal strain (C18/dcl2pro-eGFP) infected by each virus, and subjected to
northern blotting to monitor dcl2 and egfp transcript levels. Hybridization and probe preparation
are desc ibed in the Materials and M thod s ction. Mean values of band intensity in the northern
blots (C) qua tified by ImageJ are shown below each blot. RT-PCR detection for CHV4 infection or
dsRNA electrophoretic gel analysis for MyRV2 (viral dsRNA genome) or CHV1 and CHV1-∆p69
(viral replicative dsRNA form) infection in the reporter fungal strain were conducted. Ribosomal
RNA (28S rRNA) was used as a loading control.
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These results confirm that CHV4 is able to impair the otherwise strong transcriptional
induction of dcl2 triggered by infection with heterologous viruses (MyRV2 or CHV1-p69)
that otherwise induce antiviral RNA silencing.
3.2. Co-infection Results in Alterations in Profiles of Virus-Derived Small RNAs
Previous results have shown that the disruption of dcl2 in C. parasitica affects the
small RNA profile of CHV1-∆p69 [40]. To investigate the small RNA profiles of CHV4-C18
and MyRV2 in single and double infections, small RNAs were deep-sequenced. The C.
parasitica strain C18 infected with CHV1-EP713, a hypovirus with a well-characterized
RNA silencing suppressor, was used as a reference. CHV1 derived small RNAs showed
lesser accumulation in their negative-strands (27%) than the positive-strands (73%), both
having a peak of 21 nt as reported by Zhang et al. [12] (Figure 2A,B).
Biology 2021, 10, x 6 of 15 
 
 
Previous results have shown that the disruption of dcl2 in C. parasitica affects the 
small RNA profile of CHV1-∆p69 [40]. To investigate the small RNA profiles of CHV4-
C18 and MyRV2 in single and double infections, small RNAs were deep-sequenced. The 
C. parasitica strain C18 infected with CHV1-EP713, a hypovirus with a well-characterized 
RNA silencing suppressor, was used as a reference. CHV1 derived small RNAs showed 
lesser accumulation in their negative-strands (27%) than the positive-strands (73%), both 
having a peak of 21 nt as reported by Zhang et al. [12] (Figure 2A and B). 
 
Figure 2. Viral-derived small RNA profiling of C. parasitica C18 strain in either singly or doubly 
infected by CHV4-C18 and MyRV2. (A) Sense and small antisense RNAs (15 to 32 nt) derived from 
singly or doubly infected CHV4-C18 and MyRV2 are shown on a per-million-total-small-RNA 
read (the y-axis represents the one-thousandth read numbers). The C18 strain infected singly by 
CHV1-EP713 (wild type) was also included for the analysis as a reference. The percentage shown 
on each bar represents the ratio of negative strand small RNAs. (B) Size distributions of small 
RNAs derived from CHV1 in singly infected C18. (C) Size distributions of virus-derived small 
RNAs in single and double infections of strain C18 by CHV4-C18 and/or MyRV2. Blue and red 
bars denote plus-strand and minus-strand small RNAs (B,C). 
Interestingly, single infection by CHV4-C18 showed a unique small RNA profile that 
has a size distribution without a sharp 21-nt peak in the positive-strand small RNAs, no 
preferential nucleotide at their 5′ termini, and a high preponderance of the small RNAs 
being of positive-strand polarity (94.5%) (Figure 2A and C, Figure S2). This is similar to 
the profile in the dcl2 mutant in the EP155 genetic background when infected with either 
CHV1-p69 or a mitochondrially replicating mitovirus CpMV1 (Cryphonectria mitovirus 
Figure 2. Viral-derived s all R A profiling of C. parasitica C18 strain in either singly or doubly
infected by CHV4-C18 and MyRV2. (A) Sense and small antisense RNAs (15 to 32 nt) derived from
singly or doubly infected CHV4-C18 and MyRV2 are shown on a per-million-total-small-RNA read
(the y-axis represents the one-thousandth read numbers). The C18 strain infected singly by CHV1-
EP713 (wild type) was also included for the analysis as a reference. The percentage shown on each
bar represents the ratio of negative strand small RNAs. (B) Size distributions of small RNAs derived
from CHV1 in singly infect d C18. (C) Size distributions of virus-derived small RNAs in single and
double i fection of strain C18 by CHV4-C18 and/or MyRV2. Blue and red bars denote plus-strand
and minus-strand small RNAs (B,C).
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Interestingly, single infection by CHV4-C18 showed a unique small RNA profile that
has a size distribution without a sharp 21-nt peak in the positive-strand small RNAs, no
preferential nucleotide at their 5′ termini, and a high preponderance of the small RNAs
being of positive-strand polarity (94.5%) (Figure 2A,C, Figure S2). This is similar to the
profile in the dcl2 mutant in the EP155 genetic background when infected with either
CHV1-p69 or a mitochondrially replicating mitovirus CpMV1 (Cryphonectria mitovirus
1) [40,41]. This unusual pattern of CHV4 small RNA profile may be associated with the
lower accumulation of viral replicative dsRNA and no or very weak dcl2 induction in
the fungal hosts [28,42]. Co-infection by MyRV2 led to enhanced accumulation of both
strands of CHV4-derived small RNAs with a clear 21-nt peak (Figure 2A,C), likely through
modest induction of dcl2 by MyRV2 compared to single infection by CHV4 (Figure 1C).
An almost equal amount of small RNAs derived from the MyRV2 positive and negative
strands accumulated in single or double infections (Figure 2A,C). MyRV2-derived small
RNAs had a clear peak at 21-nt in both the positive and negative strands. Co-infection with
MyRV2 led to CHV4-derived small RNA distribution with the size of 21 nt as the highest
peak showed for both small RNA strands (Figure 2C). Co-infection by CHV4 had a modest
positive impact on the accumulation of both strands of MyRV2-derived small RNAs, i.e.,
approximately two-fold increase observed in double infections relative to single infections
(Figure 2A). This increase appeared to be due to the CHV4-mediated suppression of dcl2
transcriptional induction by MyRV2 and increased MyRV2 accumulation (see below). The
relative accumulation of virus-derived small RNAs and dcl2 was inversely correlated, and
yet was non-proportional, as reported earlier by Andika et al. [35].
3.3. CHV4 Encodes a Papain-Like Cysteine Protease p24
The family Hypoviridae contains four species whose exemplar strains were derived
from C. parasitica: CHV1, CHV2, CHV3, and CHV4 [43]. CHV2 and CHV3 have been
shown to encode one papain-like cysteine protease at the most N-terminal portion of the
polyprotein, while CHV1 possesses two proteases. Linder-Basso et al. [42] characterized the
prototype CHV4 isolate SR2 (CHV4-SR2) and predicted the catalytic cysteine (Cys173) and
histidine residues (His223), and self-cleavage di-glycine site (Gly245 Gly246). Although
the two CHV4 isolates from USA, SR2 and C18, share over 99% nucleotide sequence
identity, a single nucleotide polymorphism in the 5’ proximal region results in different
initiation codon positions 194 for CHV4-SR2 and positions 287 for CHV4-C18, leading
a difference in polyprotein size (31 codons shorter in CHV4-C18) [28]. To examine the
possible biological function of CHV4-C18 p24, we referred to available information on a
well-established hypoviral papain-like cysteine protease CHV1 p29 [21,22], which also acts
as an RNA silencing suppressor [26], a symptom determinant [23,24,44], and part of an
IRES element [25].
To test the hypothesis that CHV4-C18 p24 is a papain-like cysteine protease, an E. coli
expression construct was prepared, as shown in Figure 3A. The N-terminal fragment of
the CHV4-C18 polyprotein (52 kDa polypeptides), including the tentative protease p24
coding domain, which carried a His-tag and GST at the N-terminus and an HA-tag at
the C-terminus, was expressed in E. coli cells. The expected total molecular mass of the
recombinant protein (His/GST-CHV4 52kDa-HA) is ~84 kDa.
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free isogenic isolate of C. parasitica C18 strain. Five transformants (designated as C18p24-
1 to -5) were tested for the suppression of the dcl2 transcriptional upregulation following 
infection by MyRV2 as an RNA silencing trigger [28]. Lower induction of the dcl2 tran-
scription was observed in transformants expressing CHV4-C18 p24 (29% for 
C18p24/MyRV2) relative to non-transformants (expressed as 100% for C18/MyRV2), and 
this suppression was slightly smaller than that in CHV4 co-infection (18% for 
Figure 3. Autocatalytic proteolytic activity of CHV4 p24 encoded at the most N terminal portion
of the viral polyprotein. (A) Schematic representation of the N terminal portion of the CHV4-C18
polyprotein. The N-terminal coding regions spanning amino acids 1 to 473 (the estimated molecular
weight of ~ 52 kDa) was cloned into the KpnI-NdeI site of an Escherichia coli expression vector, pCold.
The 52kDa coding region was fused in frame with a His-tag and GST at the N-terminus and an HA-tag
at the C-terminus (pCold-His/GST-CHV4 52kDa-HA, 86 kDa). The predicted ystein nd histidine
residues and di-glycine are shown on the top. (B) The self-cleavage act vity of CHV4-C18 p24 in the
recombinant E. coli cells. Total protei s in E. coli cells transformed by the CHV4-52kDa expression
construct and empty vector were electrophoresed in SDS-PAGE gel and stained with Coomassie
Brilliant Blue. Two protein bands of 52kDa and 28 kDa were specifically induced in the recombinant
cells with the CHV4-52kDa construct upon induction (left panel, shown with arrows). Unpurified
fractions of the over-expressed protein encoded by the N terminal portion of CHV4 were blotted
onto PVDF membrane, and the 28 kDa protein band was subjected to chemical sequencing. The six
determined amino acid residues were the same as those deduced from the CHV4 nucleotide sequence.
The cleavage site was experimentally identified as Gly245↓Gly246, which had been predicted by
Linder-Basso et al. [41].
To test whether CHV4 p24 had auto-proteolytic activity, total protein fractions of E.
coli cells transformed by the pCold-construct were examined by SDS-PAGE Figure 3B.
Two protein bands of 58 kDa and 25 kDa were specifically induced in transformed E. coli
cells upon induction by cold shock and IPTG treatment. From the predicted cleavage
site of p24, the two products were assumed likely to be a fusion of His-GST-CHV4 p24
(~53kDa) and CHV4-remaining polypeptides (amino acids 214–473) with HA-tag (~28kDa),
respectively. These two protein bands were observed n ither in c lls transformed with the
expr ssion construct, pCold-His/GST-CHV4 52kDa-HA, under non-induced condition ,
nor in cells transformed cells with the em ty vector regardless of wheth r under induced or
non-induced conditions. The N-terminal sequence of the 25 kDa-pro uct was etermined
to be G-R-E-S-D-A-D-S-H-P, identical to the CHV4-C18 poly rotein sequence at 215 to 224
and in agreement with the prediction for the CHV4-SR2 strain by Linder-Basso et al. [42]
(Figure 3).
These results show that CHV4 encodes a papain-like protease, designated as p24,
which cleaves itself from the N-terminal portion of the polyprotein at a di-glycine site
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(ARLG GRES) likely in a co-translational manner as in the case for the peptidase C7
superfamily homologs of other C. parasitica hypoviruses [22,45].
3.4. CHV4-C18 p24 Compromises dcl2 Upregulation and Enhances MyRV2 Accumulation
The multifunctional protein CHV1 p29 was the first RNA silencing suppressor identi-
fied from mycoviruses [26,46]. CHV1 p29 exerts its suppressor activity by inhibiting the
transcriptional upregulation of the RNA silencing key enzyme genes, dcl2 and agl2. To
investigate whether CHV4-C18 p24, a putative homolog of CHV1 p29, exhibits RNA silenc-
ing suppressor activities, the corresponding p24 ORF region was expressed in a virus-free
isogenic isolate of C. parasitica C18 strain. Five transformants (designated as C18p24-1 to -5)
were tested for the suppression of the dcl2 transcriptional upregulation following infection
by MyRV2 as an RNA silencing trigger [28]. Lower induction of the dcl2 transcription was
observed in transformants expressing CHV4-C18 p24 (29% for C18p24/MyRV2) relative to
non-transformants (expressed as 100% for C18/MyRV2), and this suppression was slightly
smaller than that in CHV4 co-infection (18% for C18/MyRV2+CHV4) (Figure 4, top row).
Such suppression was not observed in transformants with the empty vector (Figure S3).
Note that the difference in dcl2 mRNA accumulation between the MyRV2-infected C18
wild type strain and the other fungal strains was statistically significant (Figure S3).
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Figure 4. Suppression of transcriptional upregulation of dcl2 by CHV4-C18 p24. Total RNA fractions
were obtained from fungal strains shown on the top. C. parasitica C18 non-transformants infected
by MyRV2 (C18/MyRV2), and MyRV2 plus CHV4 (C18/MyRV2+CHV4), CHV4 p24 transformants
uninfected (C18p24-VF) or infected by MyRV2 (C18p24/MyRV2). Four independent transformants
(1 to 5) were tested in this experiment. Total RNA was examined by northern blotting for dcl2
transcripts, MyRV2 S10 mRNA, and CHV4-C18 p24 transgene transcripts. Ribosome RNA (rRNA)
serves as a loadin control. Mean values of band intensity in the northern blots quantified by ImageJ
are shown b low each blo . Note that the presenc of CH 4 genomic RNA was confirmed in fungal
strain C18 doubly infected MyRV2 and CHV4.
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MyRV2 accumulation in CHV4-C18 p24 transformants, represented by the S10 seg-
ment, compared with that in non-transformant C18 in the absence or presence of CHV4-C18.
Interestingly, transgenic expression of CHV4-C18 p24 enhanced MyRV2 accumulation,
though not as greatly as CHV4-C18 co-infection, (Figure 4, second row). MyRV2 accumula-
tion was slightly higher, albeit not at statistically significant levels (Figure S4), in the p24
transformants (approximately 1.6-fold relative to wild-type C18) than in non-transformants
not infected by CHV4-C18, but much lower than in lines co-infected by CHV4-C18 (ap-
proximately 5-fold relative to wild-type C18) (Figure 4, second row). Enhanced MyRV2
accumulation was not observed in transformants with the empty vector pCPXHY3, which
showed slightly lower MyRV2 accumulation than C18p24 (Figure S3).
3.5. CHV4-C18 p24 Enhances MyRV2 Stable Infection and Horizontal Transmissibility
It has previously been shown that during repeated subcultures of C. parasitica host
strain C18, CHV4-C18 co-infection enhances the stability of MyRV2, which is otherwise
susceptible to antiviral RNA silencing and is eliminated [28]. We tested whether transgenic
expression of CHV4-C18 p24 alone enhanced the stability of MyRV2 using several C18p24
transformant strains (designated C18p24-1 to -5) (Figure 5). Three MyRV2 infectants
for each of the five independent CHV4-C18 p24 transformants were examined, while
three infectants of empty vector transformants (termed C18emp) were used as controls
(Figure S2). As observed in wild-type C. parasitica wild-type strain C18 [28], MyRV2 was
more frequently lost in the control strain as subculturing proceeded (Figure S2). By contrast,
transgenic expression of CHV4-C18 p24 greatly reduced MyRV2 elimination. For example,
at the 7th subculture, 11 of 15 C18p24 infectants still carried MyRV2, while only 7 of 15
control (C18emp) infectants harbored MyRV2 as determined by RT-PCR (Figure 5). By the
10th subculture, two-thirds of control (C18emp) infectants lost MyRV2, whereas 60% of p24
transformants (C18p24) retained MyRV2 (Figure 5 and Figure S2), somewhat lower than
the 100% demonstrated previously for strains co-infected with CHV4-C18 [28]. MyRV2
was lost in 87% of subcultures of non-transformant C18 strains by the 10th subculture
in the previous work [28], while nine out of fifteen transformants (60%) retained MyRV2
during the period of 10th subculture using similar culturing conditions (Figure 4). Thus,
the degree of MyRV2 stability conferred by CHV4-C18 p24 transgenic expression was
smaller than that conferred by CHV4-C18 infection, but was much greater than that in the
non-transformant C18 strain.
We have noted that MyRV2 could rarely be moved laterally by anastomosis to wild
type C18 in the absence of CHV4-C18. We attempted to transfer MyRV2 to virus-free
C18 (C18-VF) using three plates in each of three independent co-culturing assays. We
could move MyRV2 only to two recipient colonies out of nine co-cultures. To examine
whether p24 alone could also facilitate the horizontal transmission of MyRV2, CHV4-C18
p24 transformants (C18p24), and non-transgenic controls were co-cultured with MyRV2-
infected C18 strain (C18/MyRV2) (Figure 6). Efficient horizontal transmission of MyRV2 to
recipient fungal transformants expressing p24 (C18p24) and to recipient isolates harboring
the complete virus CHV4-C18, but not to virus-free wild-type strain C18 (C18-VF). A CHV4
transfer pattern similar to that observed for C18-VF was obtained. Co-culturing using five
co-cultures yielded no CHV4 horizontal transfer to C18emp.
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Figure 5. Enhanced infection stability of MyRV2 by transgenic expression of CHV4-C18 p24. (A,C) De-
tection of MyRV2 infection by RT-PCR in C18 transformants with the CHV4 p24 coding domain
(C18p24) or the empty vector (C18emp). Virus infection in three transfectant subisolates from 5 inde-
pendent transformants (lines 1 to 5) was monitored until 10th subcultures by colony RT-PCR. RT-PCR
was carried out as described by Aulia et al. [28] using the primers CHV4-287_F and CHV4-853_R.
Amplified fragments were analyzed in 1.2% agarose gel electrophoresis. (B,D) MyRV2 Infectivity
after successive fungal subculture in C18p24 transformants (B) and transformants with the empty
vector (C18emp) (D).
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Figure 6. Transgenic expression of CHV4-C18 p24 in recipient C. parasitica strains facilitates horizontal
transmission of MyRV2 via anastomosis. Non-transgenic donor isolates containing MyRV2 (left
side of panel A) were co-cultured on PDA with CHV4-C18 p24 transformants (C18p24) as recipients
(right side of panel A), or with virus-free (C18-VF) and CHV4-C18-infected (C18/CHV4) recipients
as controls. Following anastomosis, subcultures were obtained from the recipient side and tested for
MyRV2 infection by conventional dsRNA extraction and agarose gel electrophoresis (panel B).
The combined results, shown in Figures 5 and 6, strongly suggest that CHV4 p24 is an
RNA silencing suppressor, derived from the N-terminal portion of the polyprotein encoded
by CHV4.
4. Discussion
We have previously shown a commensal interaction between a symptomless hy-
povirus, CHV4-C18, and a hypovirulence-conferring mycoreovirus, MyRV2, in the C.
parasitica strain C18, in which the former virus facilitates efficient vertical transmission and
stable infection of the co-infecting second virus during subculture [28]. In the absence of
CHV4-C18, MyRV2 is unstable, is lost from culture quickly, and is unable to move efficiently
either vertically through conidia or horizontally by anastomosis, likely because it is highly
susceptible to antiviral RNA silencing. Here, we report the identification of CHV4-C18
self-cleaving protease p24 as an RNA silencing suppressor that is directly involved in this
commensalism or a one-way syn rgistic effect on a co-infecting virus.
As predicted for another CHV4 strain, SR2, by Linder-Basso et al. [42], the p tative
cleavage sit of he polyprotein was mapped to the di-glycine peptide t positions 214 nd
215 in CHV4-C18, and is strictly conserved among CHV4 isolat s sequenced, thus far, as
well as in some other hypovi uses, including CHV1, Phomop is longicolla hypovir 1 and
Valsa cerato perma ypovirus 1 [22,28,42,47]. A glycine-threonine dipept de (instead of the
second glycine) is the cleavage s te of CHV3-GH2 p32, the homolog of CHV4-C18 p24 [45].
While this study did not explore the predicted catalytic residues of CHV4-C18 p24, cysteine
142 and histidine 192 were implicated based on their conservation with similar spacing
in homologous papain-like proteases identified in many hypoviruses and related plant-
infecting potyviruses [42]. It should be noted that in addition to the papain-like cysteine
proteases of the peptidase C7 and C8 superfamilies in C. parasitica hypoviruses [48,49],
putative 2A-like proteases (a self-processing peptide motif) were recently discovered in
some closely related hypoviruses infecting Rosellinia and Fusarium fungi [50].
Suppression of RNA silencing is one of the strategies employed by viruses to coun-
teract host antiviral machinery. However, identifying RNA silencing suppressors based
on sequence comparison is not easy, because no common conserved sequence motifs are
detectable between distant virus groups. This is particularly true for fungal viruses be-
cause no robust, versatile methods for identifying RNA silencing suppressors are available.
As an antiviral defense response, key enzyme genes involved in RNA silencing (dcl and
agl) are transcriptionally upregulated upon virus infection. Here, a recently developed
reporter assay [39] was employed to confirm the RNA silencing suppressor activity of
CHV4-C18, in which dcl2 transcription induction was monitored by GFP fluorescence
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(Figure 1). The results, shown in Figure 1, further validated the method and contributed to
the identification of CHV4-C18 p24 as an RNA silencing suppressor that likely potentiates
the enhancement of vertical transmission and stability of an RNA silencing-susceptible
virus, MyRV2. Generally, virus genomic dsRNA or viral dsRNA replicative forms can
trigger antiviral RNA silencing. On the one hand, lower accumulation of the replicative
dsRNA form of CHV4 [28,42] may allow the virus to evade host RNA silencing. On the
other hand, CHV4 encodes RNA silencing suppressor p24 as a counter defense mechanism
(Figures 4–6). It is interesting to speculate whether p24 RNA silencing activity is essential
for the stable CHV4 infection in the host fungus. Relevant to this question, the relatively
few CHV4 variants examined to date display varying levels of virulence, and differences
in RNA accumulation levels in those variants have not been examined [30,42]. Thus, it
is possible that p24 silencing suppressor activity is more important for CHV4 stability in
some variants than others.
Robust systems for examining RNA silencing suppression mechanisms in virus-
infected plants are available, and many have been well studied [19,51]. Plant viral RNA
silencing suppressors target various players or steps of RNA silencing to suppress antiviral
silencing [19]. In contrast, only a limited number of RNA silencing suppressors have been
identified from fungal viruses. These include CHV1 p29 [26], MyRV3 VP10 [27], and FgV1
p2 [4]. The RNA silencing suppressor CHV1 p29 was shown to suppress the transcriptional
induction of RNA silencing key enzyme genes that are virus-responsive [2,52]. Similarly, the
RNA silencing suppressor named p2 (the ORF2 protein) recently reported from the fungal
virus FgV1, belonging to the proposed family Fusariviridae [9], functions via transcriptional
repression mechanism like CHV1 p29. The mechanism of the MyRV3 VP10 suppressor was
not determined [27]. In the case of C. parasitica, the upregulation of the key RNA silencing
genes requires the DCL2 protein, but not AGL2, in addition to the general transcriptional
co-activator, SAGA (Spt-Ada-Gcn5 acetyltransferase) complex [35,40]. It remains elusive
how these RNA silencing suppressors impair the transcriptional regulatory pathway in
fungal cells.
While CHV1 and CHV4 are members of the family Hypoviridae, they show different
and similar molecular and biological properties. CHV1 has two ORFs, A and B, each en-
coding a papain-like cysteine protease, p29 (peptidase C7 superfamily) and p48 (peptidase
C8 superfamily). CHV4 has only one ORF and encodes one single protease, p24 (peptidase
C7 superfamily). CHV1 has been reported from Asia, Europe, and North America and
induces hypovirulence in C. parasitica together with associated phenotypic alterations that
vary in degree depending on the fungal strains. CHV4 is generally asymptomatic and has
been only reported from the USA and it is pervasive in the country [53]. Despite these dif-
ferences, it is of interest to note that CHV4-C18 p24 and CHV1 p29 are both multifunctional
and show interesting parallels: Both proteins can self-cleave at their C-termini, and both
suppress antiviral RNA silencing via inhibition of the upregulation of the RNA silencing
key genes, including dcl2. Additional roles assigned to CHV1 p29 include its action as a
symptom determinant [23,24,44], and a part of IRES [25]. It will be an interesting future
challenge to investigate whether CHV1 p29 and CHV4 p24 have the same mode of action
as RNA silencing suppressors and whether another CHV1 p29 homolog, CHV3 p32, has
an RNA silencing suppressor function.
5. Conclusions
In conclusion, we have described a functional role of CHV4 p24 in RNA silencing
suppression. CHV4 p24, encoded by the 5′-terminal portion of the single large open reading
frame, is cleaved from the large polyprotein by its autocatalytic protease activity between
the two glycine residues at Gly214 and Gly215. Transgenic expression of CHV4 p24 led to
reduced levels of the upregulation of the antiviral RNAi key genes, dcl2, upon infection
by a trigger virus, MyRV2, and enhanced levels of MyRV2 content. Furthermore, CHV4
p24 enhanced the maintenance of MyRV2 during subculturing and horizontal transfer
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during co-culturing. These combined results allowed us to identify CHV4 p24 as an RNA
silencing suppressor.
Supplementary Materials: The following are available online at https://www.mdpi.com/2079-7
737/10/2/100/s1, Figure S1: The 5′-terminal nucleotide profile of viral-derived small RNA (15-
to 32 nt) of C. parasitica C18 strain in either singly or doubly infected by CHV4-C18 and MyRV2,
Figure S2: Instable MyRV2 infection in strain C18 transformed with an empty vector, Figure S3:
Quantitative analyses of dcl2 or MyRV2 S4 mRNA in C18 transformed by the empty vector and p24
coding domain. different fungal strains, Figure S4: Quantification of dcl2 or MyRV2 S10 mRNA in
different fungal strains. Bar graphs show the relative accumulation levels (mean ± SD, n = 2–5) of
dcl2 or MyRV2 S10 mRNA based on the northern blotting data shown in Figure 4. Table S1: List of
primers used for analyzing CHV4-C18 RNA silencing suppression.
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